Ahmed S. Abdelsamie

Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity

Shadia A. Galal, Sarah H. M. Khairat, Fatma A.F. Ragab et al. · European Journal of Medicinal Chemistry · 2014 · 132 citations · Full text

Medicinal Chemistry, Novel Quinoxalin-2, Medicine +11

Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives

Shadia A. Galal, Ahmed S. Abdelsamie, Harukuni Tokuda et al. · European Journal of Medicinal Chemistry · 2010 · 70 citations

Combinatorial Chemistry, Engineering, Medicine +9

A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate <i>Pseudomonas aeruginosa</i> Biofilms

Christian Schütz, Duy‐Khiet Ho, Mostafa M. Hamed et al. · Advanced Science · 2021 · 56 citations · Full text

Design, synthesis and structure–activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor

Shadia A. Galal, Ahmed S. Abdelsamie, Salwa M. Soliman et al. · European Journal of Medicinal Chemistry · 2013 · 47 citations

Structure–activity Relationship, Medicine, Drug Discovery +6

Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs

Shadia A. Galal, Ahmed S. Abdelsamie, Samia A. Shouman et al. · European Journal of Medicinal Chemistry · 2017 · 43 citations · Full text

Drug Target, Health Sciences, Checkpoint Kinase 2 +11